» Articles » PMID: 22138891

Ten-year Prospective Follow-up of Histological Changes at Five Points on the Gastric Mucosa As Recommended by the Updated Sydney System After Helicobacter Pylori Eradication

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 2011 Dec 6
PMID 22138891
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atrophic gastritis and intestinal metaplasia (IM) are well known as precancerous lesions of gastric cancer. The present study evaluated the gastric mucosa for 10 years after H. pylori eradication at five points of the stomach as recommended by the updated Sydney system to clarify the relationship between H. pylori eradication and gastric cancer prevention.

Methods: Among the comprised 373 patients, 323 were H. pylori-positive while 50 patients were H. pylori-negative. Patients with successful eradication underwent follow-up endoscopic examination every year. Biopsy specimens were taken from five points of the stomach, as recommended by the updated Sydney system, and were evaluated for the degree of gastritis prospectively.

Results: Two hundred ninety-four out of the 323 H. pylori-positive patients successfully achieved eradication. Of the 197 patients on whom five-point biopsy was performed, the courses of 30 patients were able to be observed every year for 10 years after successful eradication. Inflammation, activity, and atrophy score at all five points were significantly reduced half a year to 6 years after eradication. IM scores fluctuated intensely up and down during all observation periods; however, IM score of the lesser curvature of the corpus continued decreasing gradually and showed a significant decrease 6 years after (0.97 ± 0.09 to 0.42 ± 0.17, P < 0.05).

Conclusion: In 10 years after H. pylori eradication, atrophy at all sites and IM in the lesser curvature of the corpus gradually and significantly decreased. These results suggest that the improvement of gastric atrophy and IM might have association with the reduction of gastric cancer occurrence.

Citing Articles

Endoscopic risk factors to inform early detection of gastric cancer after eradication: Meta-analysis and systematic review.

Kodama M, Handa O, Sugimoto M, Kotachi T, Kobayashi M, Take S DEN Open. 2025; 5(1):e70086.

PMID: 40017510 PMC: 11865013. DOI: 10.1002/deo2.70086.


Predictors of the Development of Gastric Cancer in Post--Eradication Patients Followed Up for More than 10 Years: A Histological, Serological, and Endoscopic Study.

Mizukami K, Kodama M, Hirashita Y, Fukuda M, Ozaka S, Tsutsumi K Cancers (Basel). 2025; 17(3).

PMID: 39941917 PMC: 11816399. DOI: 10.3390/cancers17030552.


Clinicopathologic Features of Early Gastric Cancer after Eradication in Japanese Patients: Comparative Study between Early (<10 Years) and Late (>10 Years) Onset.

Teshima H, Kotachi T, Kuwai T, Tsuboi A, Tanaka H, Yamashita K Cancers (Basel). 2024; 16(18).

PMID: 39335126 PMC: 11429991. DOI: 10.3390/cancers16183154.


Long-term endoscopic gastric mucosal changes up to 20 years after Helicobacter pylori eradication therapy.

Iwata E, Sugimoto M, Akimoto Y, Hamada M, Niikura R, Nagata N Sci Rep. 2024; 14(1):13003.

PMID: 38844563 PMC: 11156848. DOI: 10.1038/s41598-024-63928-6.


Multicenter study of invasive gastric cancer detected after 10 years of eradication in Japan: Clinical, endoscopic, and histopathologic characteristics.

Kobayashi M, Fujisaki J, Namikawa K, Hoteya S, Sasaki A, Shibagaki K DEN Open. 2024; 4(1):e345.

PMID: 38434145 PMC: 10908369. DOI: 10.1002/deo2.345.


References
1.
Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T . Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002; 99(22):14428-33. PMC: 137900. DOI: 10.1073/pnas.222375399. View

2.
Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y . Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003; 38(4):339-47. DOI: 10.1007/s005350300061. View

3.
Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C . Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer. 2009; 125(11):2697-703. DOI: 10.1002/ijc.24591. View

4.
Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T . Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007; 13(4):470-6. DOI: 10.1038/nm1566. View

5.
Watanabe H, Yamaguchi N, Kuwayama H, Sekine C, Uemura N, Kaise M . Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients. J Int Med Res. 2003; 31(5):362-9. DOI: 10.1177/147323000303100502. View